- Author:
Philip D BARDWELL
1
;
Matthew M STARON
1
;
Junjian LIU
1
;
Qingfeng TAO
1
;
Susanne SCESNEY
2
;
Gail BUKOFZER
3
;
Luis E RODRIGUEZ
3
;
Chee-Ho CHOI
1
;
Jennifer WANG
1
;
Qing CHANG
1
;
Feng DONG
1
;
Cherrie DONAWHO
3
;
Jieyi WANG
3
;
Christine M GRINNELL
4
;
Edit TARCSA
4
;
Charles HUTCHINS
5
;
Tariq GHAYUR
1
;
Jijie GU
6
Author Information
- Publication Type:Journal Article
- Keywords: DVD-Ig; Half DVD-Ig; Halfbody; epidermal growth factor receptor; rCTL; redirected T-cell cytotoxicity
- MeSH: Animals; Antibodies, Bispecific; immunology; Antibodies, Monoclonal; immunology; pharmacokinetics; CD3 Complex; metabolism; Cell Line, Tumor; Cytotoxicity, Immunologic; ErbB Receptors; metabolism; Female; Humans; Lymphocyte Activation; immunology; Mice, SCID; Neoplasms; immunology; pathology; Rats, Sprague-Dawley; T-Lymphocytes, Cytotoxic; immunology
- From: Protein & Cell 2018;9(1):121-129
- CountryChina
- Language:English
- Abstract: Novel biologics that redirect cytotoxic T lymphocytes (CTLs) to kill tumor cells bearing a tumor associated antigen hold great promise in the clinic. However, the ability to safely and potently target CD3 on CTL toward tumor associated antigens (TAA) expressed on tumor cells remains a challenge of both technology and biology. Herein we describe the use of a Half DVD-Ig format that can redirect CTL to kill tumor cells. Notably, Half DVD-Ig molecules that are monovalent for each specificity demonstrated reduced non-specific CTL activation and conditional CTL activation upon binding to TAA compared to intact tetravalent DVD-Ig molecules that are bivalent for each specificity, while maintaining good drug like properties and appropriate PK properties.